Lisa shares the story of her son Jace, who faced his diagnosis of a rare brain cancer with courage and compassion. His outlook continues to inspire the support Lisa now offers to other families navigating childhood cancer.

For people living with small cell lung cancer (SCLC), treatment decisions often come quickly and carry great importance. Resources like our Doctor Discussion Guide or Maintenance Therapy Fact sheet can help you be informed, active participants in your care journey. 

A medical emergency in a gym class started Megann’s life-changing journey with epilepsy, including a sudden diagnosis and intense treatment plan. Discover Megann’s inspiring story, detailing her challenges with treatment, loss of independence and how she empowers herself and other to live life to the fullest.

We strive to put patient priorities first in our research, advancing our understanding of sleep conditions and the needs of those with narcolepsy and idiopathic hypersomnia.

People with sleep conditions, such as narcolepsy and idiopathic hypersomnia, have an increased prevalence of cardiovascular comorbidities compared to people without these sleep conditions. At Jazz, we aim to raise awareness of these connections through our research and partnerships with the goal of providing patients and healthcare providers with meaningful insights that can impact their lives.

As we deepen our commitment to oncology, we’re focused on bringing forward meaningful innovation for patients, especially those facing rare and aggressive cancers like H3 K27M-mutant diffuse midline glioma. With the FDA approval of the first treatment for this cancer, there is new hope for patients and families who are navigating this life-threatening disease. 

For years, relapse after initial therapy has defined the outlook for people with extensive-stage small cell lung cancer (ES-SCLC). The FDA approval of a first-line maintenance combination regimen marks an important step forward, building on past progress and creating the possibility of longer-lasting benefit for patients and families.

Our teams at Jazz recognize the importance of collaborating with and learning from the sleep community. Our ongoing data generation is fueled by insights from people living with narcolepsy and idiopathic hypersomnia and expand our understanding of the realities of people living with these conditions.

We are focused on advancing innovation where it matters most for people facing some of the toughest cancers. Explore how our commitment to high-unmet need diseases like extensive-stage small cell lung cancer (ES-SCLC) is helping to drive meaningful progress in cancer care.